Ionis: First-In-Class drug bepirovirsen enters phase 3 clinical trials Ionis: First-In-Class drug bepirovirsen enters phase 3 clinical trials. Clearing...
Day: February 6, 2023
The application prospect of CRISPR/Cas9 in Alzheimer's disease The application prospect of CRISPR/Cas9 in Alzheimer's disease.Alzheimer's disease ( AD...
Does Vitamin D Supplementation Work? Does Vitamin D Supplementation Work? Effects May Depend on Your Weight, New Study Shows....
